American College of Cardiology Accepts SOZO HF Abstract
Filed with ASX · · 3 pages · English
Earlier from ImpediMed
- Appendix 4C - Quarter ended 31 December 2020
- PREVENT Trial Finishes, Final Patient Completes Follow-up
- Option Exercise and Preliminary Quarterly Cash Flow Results
- Meta-Analysis-BIS L-Dex Statistically Significant Reduction
- ImpediMed Secures First Commercial Heart Failure Sales
Later from ImpediMed
- Appendix 4D - Half-Year Results Ended 31 December 2020
- ImpediMed Achieves Milestone 200,000 SOZO Patient Tests
- Option Exercise and Preliminary Q3 FY21 Cashflow Results
- SOZO Clinical Utility in Heart Failure Published
- FDA Clearance for SOZO Heart Failure Index
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed